Pipeline
Extensive therapeutic potential
MP compounds restore the balance of calcium inside stressed cells by stabilizing key protein–channel interactions. This unique mechanism addresses one of the root causes shared by many neurodegenerative diseases, giving MP molecules broad therapeutic potential across multiple pathologies.
MP-004
Our lead candidate for retinal dystrophies.
Mutation-agnostic treatment
A potential therapy for all RP patients.
Dual mechanism of action
Restores calcium balance and reduces oxidative stress.
Proven efficacy
Improves photoreceptor structure and function.
Low toxicity
Favorable safety profile demonstrated across species.
Optimized properties
Favorable physicochemical characteristics and ADME profile.
Combinable treatment
Shown to work alone, with potential to be used with other therapies.
Non-invasive delivery
Reaches the retina through topical ocular instillation.
Scalable and sustainable production process
Simple click-chemistry synthesis enables large-scale manufacturing while minimizing the use of toxic reagents and metals.
MP-004
Our lead candidate for retinal dystrophies.
01
Mutation-agnostic treatment
A potential therapy for all RP patients.
02
Dual mechanism of action
Restores calcium balance and reduces oxidative stress.
03
Proven
efficacy
Improves photoreceptor structure and function.
04
Low
toxicity
Favorable safety profile demonstrated across species.
05
Optimized properties
Favorable physicochemical characteristics and ADME profile.
06
Combinable treatment
Shown to work alone, with potential to be used with other therapies.
07
Non-invasive delivery
Reaches the retina through topical ocular instillation.
08
Scalable and sustainable production process
Simple click-chemistry synthesis enables large-scale manufacturing while minimizing the use of toxic reagents and metals.